At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. Part 1 of this podcast series features exclusive conversations on machine learning for myelodysplastic syndromes risk prognostication, ways to reduce the use of stigmatizing language in the electronic medical record, ethical concerns surrounding AI in cancer care, efforts to create a more equitable blood donation and transfusion system, and much more!

Oncology Data Advisor at the American Society of Hematology (ASH) 2023: Part 1

ASH Annual Meeting 2023 - Full Playlist

At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. This podcast series features exclusive conversations on breaking data for novel therapies, technological innovations in hematology/oncology, efforts to reduce disparities and improve health equity, and more!

Investigating CD19-Targeted CAR T Cells for Autoimmune Diseases: Fabian Mueller, MD

Advancing Inclusion for Blood Donation Systems for Marginalized Groups: Warren Fingrut, MD

Lowering Talquetamab Dosing Intensity to Improve Tolerability: Ajai Chari, MD

Addressing Ethical Concerns Around Artificial Intelligence in Cancer Care: Andrew Hantel, MD

Expanding Access to Brexucabtagene Autoleucel for Mantle Cell Lymphoma: Andre Goy, MD

Reducing Stigmatizing Language in the EMR for More Equitable Care: Alex Boucher, MD

The mission of Oncology Data Advisor is to provide the multidisciplinary team with expert insights into clinical best practices and research progress in cancer care.

Investigating CD19-Targeted CAR T Cells for Autoimmune Diseases: Fabian Mueller, MD

Oncology Data Advisor®